                         SEQUENCE LISTING

<110>  Sequella, Inc.
 
<120>  Improved Methods and Compositions for Determining the Pathogenic 
       Status of Infectious Agents

<130>  SEQ-0706WP

<140>  PCT/US2011/022161
<141>  2011-01-21

<150>  US 61/297,056
<151>  2010-01-21

<150>  US 61/371,646
<151>  2010-08-06

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  939
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1
gcggccgcaa gcagcataac ctttttccgt gatggtaact tcacggtaac caagatgtcg       60

agttaaccac ccaaggccat ccgtcaggat ggccttgttt aaacctctgc acaggcacgt      120

ctggatgcac gtcgccgcgc aggtatggct cgcggtcttt aattgcctat ttaggtgaca      180

ctatagaagt taattaattg gttctacata aatgcctaac gactatccct ttggggagta      240

gggtcaagtg actcgaaacg atagacaact tgctttaaca agttggagat atagtctgct      300

ctgcatggtg acatgcagct ggatataatt ccggggtaag attaacgacc ttatctgaac      360

ataatgctac cgtttaatat tcgtggcctt tgtcaccgac gcctactcga ggggttaatg      420

taaaaaccga ccagaatcat gcaagtgcgt aagatagtcg cgggccggga aaaacattgg      480

cccctcgagg gacaacgccg aattgcgaag ggctatcagt ttaatgtgcg taaacgacca      540

catcaaccat gcatgatctt ctactacatc agcttttaga tttttcacgc ttactgcttt      600

tttcttccca agatcgaaaa tttactgaat taacaatgga ttctgaggtt gctgctttgg      660

ttattgataa cggttctggt atgtgtaaag ccggagctca gatgttttct tgggttaatt      720

gaggcctgag tataaggtga cttatacttg taatctatct aaacggggaa cctctctagt      780

agacaatccc gtgctaaatt gtaggactgc cctccggacc tatgccctat ctaccttgcg      840

taggtagggt tctttttagc ataacccctt ggggcctcta aacgggtctt gaggggtttt      900

tttatcctta atccttagcg aaagctaagg atttttttt                             939


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2
taggcgtcgg tgacaaaggc cacg                                              24


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3
ggacaacgcc gaattgcgaa gggc                                              24


